MAGGIORA, Piera
 Distribuzione geografica
Continente #
NA - Nord America 195
EU - Europa 129
AS - Asia 57
AF - Africa 1
Totale 382
Nazione #
US - Stati Uniti d'America 192
CN - Cina 32
UA - Ucraina 24
SE - Svezia 23
DE - Germania 19
IE - Irlanda 15
FI - Finlandia 12
FR - Francia 12
KR - Corea 12
GB - Regno Unito 10
SG - Singapore 10
IT - Italia 7
PL - Polonia 4
CA - Canada 3
RU - Federazione Russa 2
IN - India 1
NL - Olanda 1
SN - Senegal 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 382
Città #
Chandler 28
Beijing 25
Dublin 15
Woodbridge 14
Ann Arbor 11
Ashburn 11
Dearborn 11
Houston 11
Jacksonville 11
Villeurbanne 9
Medford 7
Singapore 7
Princeton 6
Falls Church 5
Boardman 4
Menlo Park 4
Warsaw 4
Wilmington 4
Düsseldorf 3
Milan 3
Nyköping 3
Boston 2
Hefei 2
Santa Clara 2
Toronto 2
Verona 2
Washington 2
Cambridge 1
Dong Ket 1
Fuzhou 1
Guangzhou 1
Jinan 1
Lachine 1
Leawood 1
Munich 1
Nanchang 1
Nanjing 1
Norwalk 1
Philadelphia 1
Pune 1
Torino 1
Turin 1
Totale 223
Nome #
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression 81
Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro 70
Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms. 69
erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. 68
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. 63
Feline stk gene expression in cat mammary carcinomas 44
Totale 395
Categoria #
all - tutte 1.455
article - articoli 0
book - libri 0
conference - conferenze 180
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 6 4 6 18 8 2 6 5 2 0
2020/202141 4 0 6 3 5 2 3 1 9 3 2 3
2021/202251 1 1 3 3 3 4 3 2 2 3 12 14
2022/202377 11 2 2 4 14 14 8 4 13 0 4 1
2023/202432 3 5 3 2 4 11 0 0 0 0 1 3
2024/202510 0 10 0 0 0 0 0 0 0 0 0 0
Totale 395